ACH — ACCENDRA HEALTH INC/VA/
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ACH
| date | signal | measured base rate |
|---|---|---|
| 2026-08-12 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-05-11 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-05-18 | Galloway Heath H EVP,General Counsel & CorpSecy | Shares withheld for tax | 1.8K | 2.91 | 5.3K |
| 2026-05-15 | Pesicka Edward A President & CEO | Shares withheld for tax | 17.7K | 3.04 | 53.8K |
| 2026-05-15 | Bernocchi Perry A EVP, Chief Operating Officer | Shares withheld for tax | 7.9K | 3.04 | 24.0K |
| 2026-05-15 | Leon Jonathan A EVP & CFO | Shares withheld for tax | 1.8K | 3.04 | 5.4K |
| 2026-05-15 | Galloway Heath H EVP,General Counsel & CorpSecy | Shares withheld for tax | 966 | 3.04 | 2.9K |
| 2026-05-14 | Gardner-Smith Kenneth Director | Grant or award | 31.2K | 0.00 | 0 |
| 2026-05-14 | Klemash Stephen W Director | Grant or award | 31.2K | 0.00 | 0 |
| 2026-05-14 | Kline Teresa L. Director | Grant or award | 31.2K | 0.00 | 0 |
| 2026-05-14 | Beck Mark A Director | Grant or award | 31.2K | 0.00 | 0 |
| 2026-03-20 | Pesicka Edward A President & CEO | Shares withheld for tax | 58.9K | 2.03 | 119.7K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Coliseum Capital Management, LLC | 29.9M | 13.1M |
| BlackRock, Inc. | 11.9M | 5.2M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8.3M | 3.6M |
| BANK OF AMERICA CORP /DE/ | 7.8M | 3.4M |
| Invenomic Capital Management LP | 7.7M | 3.4M |
| D. E. Shaw & Co., Inc. | 7.6M | 3.3M |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.5M | 3.3M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.0M | 2.7M |
| DIMENSIONAL FUND ADVISORS LP | 5.9M | 2.6M |
| GEODE CAPITAL MANAGEMENT, LLC | 4.2M | 1.8M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Accendra Health Inc/va/ (ACH) filed form 8-K · 2026-08-17 · SEC EDGAR
- Accendra Health Inc/va/ (ACH) filed form 8-K · 2026-08-10 · SEC EDGAR
- Accendra Health outlines $2.45B-$2.55B 2026 revenue and $300M-$320M adjusted EBITDA amid cost cuts and CEO retirement plan · 2026-08-10
Ask the AI about ACH
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →